alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
IIA 

115TH CONGRESS 

1ST SESSION H. J. RES. 37 

IN THE SENATE OF THE UNITED STATES 

FEBRUARY 2, 2017 

Received 

JOINT RESOLUTION 

Disapproving the rule submitted by the Department of Defense, the General Services Administration, and the National Aeronautics and Space Administration relating to 

the Federal Acquisition Regulation. 

1 Resolved by the Senate and House of Representatives

2 of the United States of America in Congress assembled, 

3 That Congress disapproves the rule submitted by the 


sradovich on DSK3GMQ082PROD with BILLS
2 

HJ 37 RDS 

1 Department of Defense, the General Services Administra2 tion, and the National Aeronautics and Space Administra3 tion relating to the Federal Acquisition Regulation (pub4 lished at 81 Fed. Reg. 58562 (August 25, 2016)), and 

5 such rule shall have no force or effect. 

Passed the House of Representatives February 2, 

2017. 

Attest: KAREN L. HAAS, 

Clerk. 


sradovich on DSK3GMQ082PROD with BILLS
PAUL BRANCH

,

Petitioner,

v.

STATE OF FLORIDA

,

Respondent.

___________________________/ IN THE DISTRICT COURT OF APPEAL

FIRST DISTRICT, STATE OF FLORIDA

NOT FINAL UNTIL TIME EXPIRES TO

FILE MOTION FOR REHEARING AND

DISPOSITION THEREOF IF FILED

C ASE NO. 1D 16

- 4976

Opinion filed December 9, 2016.

Petition Alleging Ineffective Assistance of Appellate Counsel

-- Original

Jurisdiction

.

Paul Branch, pro se

, Petitioner.

Pamela Jo Bondi, Attorney General, Tallahassee , for Respondent.

P ER CURIAM.

The petition alleging ineffective assistance of appellate counsel is denied on the

merits.

ROBERTS, C.J., ROWE and WINSOR, JJ., CONCUR.
An official website of the United States government         Here's how you know         
**Official websites use .mil**
A **.mil** website belongs to an official U.S. Department of Defense organization in the United States.
**Secure .mil websites use HTTPS**
 A **lock (lock )** or **https://** means you’ve safely connected to the .mil website. Share sensitive information only on official, secure websites.

Skip to main content (Press Enter).

U.S. Indo-Pacific CommandUSINDOPACOM

U.S. Indo-Pacific Command

Search

Search
Search

-  Home		 
-  Leadership    -  Commander         
  -  Deputy Commander         
  -  Chief of Staff         
  -  Senior Enlisted Leader 
-  About USINDOPACOM    -  History         
  -  USPACOM Area of Responsibility         
  -  USPACOM Previous Commanders         
  -  Women, Peace and Security 
-  Organization    -  Organization Chart 
-  Media    -  News      -  Spotlight 
  -  Photos         
  -  Speeches / Testimony         
  -  Freedom of Information Act      -  FOIA - Reading Room         
    -  Submit FOIA Request         
    -  Request Status         
    -  FOIA FAQS 
-  Resources    -  Travel Requirements         
  -  Useful Theater Information         
  -  FAQ         
  -  Useful Links 
-  Newcomers		 
-  Contact    -  Directory         
  -  Media Inquiries         
  -  Industry Engagements 
-  JTF - Red Hill		 
-  JTF-Micronesia		 

Home : Media : News : News Article View

PHOTO INFORMATION

** Download

** Details

** Share

# US, Japan Bomber-fighter Integration Demonstrates Commitment, Enhances Readiness

By Senior Airman River BrucePacific Air Forces Public Affairs

**                    SHARE                

**                    PRINT                

More News
##### 



Execution Copy
    
    Exhibit 10.41
 
 Second Amendment to Collaboration and License Agreement
 Amendment Amendment Effective Date Micromet AG Micromet Merck Serono
International SA, Merck Serono Party Parties
 Recitals
 Whereas Agreement
 Whereas First Amendment
 Whereas
 Now Therefore,
 Agreement
 1.
 2. Amendment to Definitions.
 1.79 Additional Clinical Study
 1.80 Micromet Program Study Report
 3. Amendment to Governance Provisions.




---



##### 



3.1 Section 2.1.2
 2.1.2 Tasks of the Steering Committee. [remainder of Section 2.1.2 remains
unchanged]
 3.2 Section 2.1.3
 2.1.3 Steering Committee Meetings. [Remainder of Section 2.1.3
unchanged]
 3.3 Section 2.1.5
 2.1.5 Decision Making.
 (a)
 (b) (i)
 (ii) provided, however
 (iii)
 (iv)
 
  2




---



##### 



3.4 Amendments relating to Project Team.
 4. Amendment to Provisions relating to Micromet Program
 4.1
 3.1 Micromet Program.
 3.1.1 Combination Study Additional Clinical Study Micromet Program Micromet Program Plan
 3.1.2 Micromet Program Study Report
 4.2
 3.3.1 Scope.
 
  3




---



##### 



4.3
 4 4
 (b)
 4.5 Amendment to Section 3.5.1
 3.5.1 Obligation provided, however,  provided, further,
 4.6 Amendment to Section 3.7.2
 3.7.2 Assignment of BI Process Development Agreement and BI Process License Agreement.
 4.7 Suspension of Obligations under Section 3.8
 4.8 Amendment to Section 3.9
 3.9 Clinical Trial Materials.
 
  4




---



##### 



5. Amendment to Section 10.3 and 10.4
 10.3 Press Releases Proposed Disclosure
 10.4 Publications [remainder of Section 10.4 remains unchanged]
 6. Amendment to Section 11.3
 11.3 Termination at Will
 7. References to Serono.
 8. Counterparts
 9. Effectiveness
 
  5




---



##### 



10. Continuing Effect
 [Space intentionally omitted]
 
  6




---



##### 



In Witness Whereof,
 Merck Serono International S.A.
    
    
    
    Micromet AGBy:
    
    /s/ Vincent Aurentz
    
    
    
    By:
    
    /s/ Jens HenneckeName:
    
    Vincent E. Aurentz
    
    
    
    Name:
    
    Jens HenneckeTitle:
    
    Authorized Representative
    
    
    
    Title:
    
    VP Business DevelopmentBy:
    
    /s/ Francois Naef
    
    
    
    By:
    
    /s/ Carsten ReinhardtName:
    
    Francois Naef
    
    
    
    Name:
    
    Carsten ReinhardtTitle:
    
    Authorized Representative
    
    
    
    Title:
    
    SVP Clinical Development
 [Signature Page of Second Amendment to Collaboration and License Agreement]
 
  7
Opinion issued September 29, 2020

In The

Court of Appeals 

For The 

First District of Texas 

————————————

NO. 01-20-00106-CV

———————————

RICHARD MORAW AND JAMES PERRY, TRUSTEES OF THE SCOTT 

FAMILY TRUST (IRREVOCABLE), Appellants

V.

KATHRYN MULLEN, Appellee

On Appeal from the 149th District Court

Brazoria County, Texas

Trial Court Case No. 102448-CV

MEMORANDUM OPINION

Appellants, Richard Moraw and James Perry, Trustees of the Scott Family 

Trust (Irrevocable), have failed to timely file a brief. See TEX. R. APP. P. 38.6(a),

38.8(a). After being notified that this appeal was subject to dismissal, appellants

notified the Court that no notice of appeal should have been filed and that the case 
2

should be dismissed.

We dismiss the appeal for want of prosecution. See TEX. R. APP. P. 38.8(a), 

42.3(b), (c), 43.2(f). We dismiss any pending motions as moot.

PER CURIAM

Panel consists of Justices Kelly, Goodman, and Countiss.
An official website of the United States government         Here's how you know         
**Official websites use .mil**
A **.mil** website belongs to an official U.S. Department of Defense organization in the United States.
**Secure .mil websites use HTTPS**
 A **lock (lock )** or **https://** means you’ve safely connected to the .mil website. Share sensitive information only on official, secure websites.

Skip to main content (Press Enter).

U.S. Indo-Pacific CommandUSINDOPACOM

U.S. Indo-Pacific Command

Search

Search
Search

-  Home		 
-  Leadership    -  Commander         
  -  Deputy Commander         
  -  Chief of Staff         
  -  Senior Enlisted Leader 
-  About USINDOPACOM    -  History         
  -  USPACOM Area of Responsibility         
  -  USPACOM Previous Commanders         
  -  Women, Peace and Security 
-  Organization    -  Organization Chart 
-  Media    -  News      -  Spotlight 
  -  Photos         
  -  Speeches / Testimony         
  -  Freedom of Information Act      -  FOIA - Reading Room         
    -  Submit FOIA Request         
    -  Request Status         
    -  FOIA FAQS 
-  Resources    -  Travel Requirements         
  -  Useful Theater Information         
  -  FAQ         
  -  Useful Links 
-  Newcomers		 
-  Contact    -  Directory         
  -  Media Inquiries         
  -  Industry Engagements 
-  JTF - Red Hill		 
-  JTF-Micronesia		 

Home : Media : News : News Article View

PHOTO INFORMATION

** Download

** Details

** Share

# U.S. Army Pacific, Navy 7th Fleet Commanders Visit the Philippines

**                    SHARE                

**                    PRINT                

More
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Commerce

###### National Oceanic and Atmospheric Administration

          - [RTID 0648-XE483]

# AGENCY:

National Marine Fisheries Service (NMFS), National Oceanic and Atmospheric Administration (NOAA), Commerce.

# ACTION:

Notice; public meeting.

# SUMMARY:

The Mid-Atlantic and New England Fishery Management Councils (Councils) will hold a public meeting of their joint Northeast Trawl Advisory Panel (NTAP).

# DATES:

                        The meeting will be held on Friday, December 13, 2024, from 12 p.m. to  1:30 p.m. For agenda details, see                         **SUPPLEMENTARY INFORMATION.**

# ADDRESSES:

                        The meeting will be held via webinar. Connection information will be posted to the calendar at                         *www.mafmc.org*                         prior to the meeting.                    

*Council address:*                         Mid-Atlantic Fishery Management Council, 800 N State Street, Suite 201, Dover, DE 19901; telephone: (302) 674-2331;                         *www.mafmc.org.*

# FOR FURTHER INFORMATION CONTACT:

Christopher M. Moore, Ph.D., Executive Director, Mid-Atlantic Fishery Management Council, telephone: (302) 526-5255.

# SUPPLEMENTARY INFORMATION:

The Councils' NTAP will meet to discuss the Operational Manual and Orientation Document. The intent of this meeting is to discuss NTAP in detail, including background, organization, purpose, and member expectation. This meeting will be an opportunity for new and existing NTAP members to discuss and learn about the goals and purposes of NTAP.

## Special Accommodations

The meeting is physically accessible to people with disabilities. Requests for sign language interpretation or other auxiliary aids should be directed to Shelley Spedden, (302) 526-5251 at least 5 days prior to the meeting date.

*Authority:*16 U.S.C. 1801*et seq.*

Dated: November 21, 2024.

Rey Israel Marquez,

Acting Deputy Director, Office of Sustainable Fisheries, National Marine Fisheries Service.

[FR Doc. 2024-27769 Filed 11-26-24; 8:45 am]

BILLING CODE 3510-22-P
<PAGE>
 
                                                                   Exhibit 10.38

                    AMENDMENT TO DISTRIBUTORSHIP AGREEMENT
                    --------------------------------------

     This Amendment is made this 17th day of October, 1994, by and between
Molecular Simulations Inc. ("MSI"), 16 New England Executive Park, Burlington,
Massachusetts  01803, and Teijin Molecular Simulations Inc. ("TMSI"), 1-1,
Uchisaiwai-cho 2-chome, Chiyoda-ku, Tokyo 100, Japan.

     MSI (formerly Polygen Corporation) and TMSI have entered into a
Distributorship Agreement dated April 1, 1992 (the "Agreement"), and the parties
desire to amend the terms and conditions of the Agreement, as described in this
Amendment.

     NOW, THEREFORE, the parties agree as follows:

1.   Territory.  Section 1(i) of the Agreement is hereby amended to read as
     ---------                                                             
follows:

     "(i) "Territory" shall mean the following countries:  Japan, South Korea,
           ---------                                                          
Taiwan, Hong Kong, China, India, Singapore, Malaysia, Australia and New
Zealand."

2.   Maintenance and Support of Existing Customers.  From and after the 
     ---------------------------------------------
effective date of this Amendment, TMSI agrees to assume responsibility for
providing maintenance and support to MSI's existing customers in the following
countries: South Korea, Taiwan, Hong Kong, China, India, Singapore, Malaysia,
Australia and New Zealand (collectively, the "AP Countries"). TMSI will be
responsible for invoicing and collecting maintenance fees (including renewals)
for all existing MSI customers in AP Countries after the effective date of this
Amendment.

3.   General.  Upon execution of this Amendment by both parties, this Amendment
     -------                                                                   
will become effective retroactive to January 1, 1994.  Except as amended hereby,
the Agreement shall remain in full force and effect.  This Amendment shall be
governed by and construed under the laws of the Commonwealth of Massachusetts,
U.S.A., excluding its conflict of laws principles.  This Amendment may be
executed in counterparts, each of which shall be deemed an original of this
Amendment.

IN WITNESS WHEREOF, the parties have caused this Amendment to be executed on the
date first written above.

MOLECULAR SIMULATIONS INC.                   TEIJIN MOLECULAR SIMULATIONS INC.
 
By:  /s/ DAVID B. HIATT                           By:  /s/ SHIGERA OZAKI
   -------------------------------------             ---------------------------
 
Name: David B. Hiatt                                   Name:  Shigera Ozaki
     -----------------------------------                    --------------------
 
Title:    Chief Financial Officer                      Title:  President
      ----------------------------------                     -------------------
**Exhibit 32.2**

STATEMENT PURSUANT TO 18U.S.C. §1350

Pursuant to 18 U.S.C.§1350, the undersigned certifies that this Quarterly Report on Form 10-Q forthe period ended September 30, 2006 fully complies with the requirements ofSection 13(a) or 15(d) of the Securities Exchange Act of 1934 and that theinformation contained in this report fairly presents, in all material respects,the financial condition and results of operations of MillenniumPharmaceuticals, Inc.
| Dated: October 31, 2006 |   | /s/ MARSHA H. FANUCCI                             |
|-------------------------|--------|---------------------------------------------------|
|                    |   | Marsha H. Fanucci                                 |
|                    |   | Senior Vice President and Chief Financial Officer |
|                    |   | (Principal financial officer)                     |

 

A signed original of this written statement requiredby Section 906 has been provided to Millennium Pharmaceuticals, Inc. and willbe retained by Millennium Pharmaceuticals, Inc. and furnished to the Securitiesand Exchange Commission or its staff upon request.

----
Exhibit 13.2



CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the annual report of Oncolytics Biotech Inc. (the Company) on Form 20-F for the fiscal year ended December 31, 2008 as filed with the Securities and Exchange Commission on the date here of (the Report), I, Doug Ball, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



(1)         The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



(2)         The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.







| | /s/ Doug Ball
__________________________________ | 
| | ------------------------------------------------ | 
| | Doug Ball, CA                                    | 
| | Chief Financial Officer                          | 
| | Principal Accounting and Financial Officer      
| | March 6, 2009                                    | 
| |                                                  | 





A signed  original of this  written  statement  required by Section 906 has
     been provided to Oncolytics Biotech Inc. and will be retained by Oncolytics
     Biotech Inc. and furnished to the Securities and Exchange Commission or its
     staff upon request.











---
```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1488 Referred in Senate (RFS)]

<DOC>
115th CONGRESS
  1st Session
                                H. R. 1488

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            November 2, 2017

   Received; read twice and referred to the Committee on Energy and 
                           Natural Resources

_______________________________________________________________________

                                 AN ACT

 
 To retitle Indiana Dunes National Lakeshore as Indiana Dunes National 
                     Park, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Indiana Dunes National Park Act''.

SEC. 2. INDIANA DUNES NATIONAL LAKESHORE RETITLED AS INDIANA DUNES 
              NATIONAL PARK.

    (a) In General.--Public Law 89-761 (16 U.S.C. 460u et seq.) is 
amended--
            (1) by striking ``National Lakeshore'' and ``national 
        lakeshore'' each place it appears and inserting ``National 
        Park''; and
            (2) by striking ``lakeshore'' each place it appears and 
        inserting ``Park''.
    (b) Nonapplication.--The amendment made by subsection (a)(1) shall 
not apply to the title of the map referred to in the first section of 
Public Law 89-761 (16 U.S.C. 460u), or to the title of the maps 
referred to in section 4 of Public Law 89-761 (16 U.S.C. 460u-3).

SEC. 3. PAUL H. DOUGLAS TRAIL.

    The 1.6 mile trail within the Indiana Dunes National Park 
designated the ``Miller-Woods Trail'' is hereby redesignated as the 
``Paul H. Douglas Trail''.

            Passed the House of Representatives November 1, 2017.

            Attest:

                                                 KAREN L. HAAS,

                                                                 Clerk.
```
EXHIBIT
32.2
  
 CERTIFICATION
PURSUANT TO
 18
U.S.C. 1350,
 AS
ADOPTED PURSUANT TO
 SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
  
 In
connection with the Annual Report of FUSA Capital Corporation (the "Company") on
Form 10-K for the period ended December 31, 2008, as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), I, Jenifer
Osterwalder, in my capacity as President, Chief Executive Officer, Principal
Financial Officer and Principal Accounting Officer of the Company, certify,
pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:
 
 The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
 
 The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
  
 /s/ Jenifer
      OsterwalderDate:  
      April 11, 2009
                Jenifer
      Osterwalder
                  President,
      Chief Executive Officer, Principal Financial and Accounting Officer and
      Director
No. 90-6055.

#### Moore *v.*Illinois.

App. Ct. Ill., 1st Dist. Certiorari denied.
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE 
FINANCIAL STATEMENTS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 1997 AND IS 
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               SEP-30-1997
<CASH>                                           9,880
<SECURITIES>                                    56,610
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                67,906
<PP&E>                                          14,340
<DEPRECIATION>                                 (4,077)
<TOTAL-ASSETS>                                  89,287
<CURRENT-LIABILITIES>                           16,568
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             1
<OTHER-SE>                                      68,689
<TOTAL-LIABILITY-AND-EQUITY>                    89,287
<SALES>                                              0
<TOTAL-REVENUES>                                16,752
<CGS>                                                0
<TOTAL-COSTS>                                   12,297
<OTHER-EXPENSES>                                13,081
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 182
<INCOME-PRETAX>                                (5,534)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (5,534)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (5,534)
<EPS-PRIMARY>                                    (.49)
<EPS-DILUTED>                                        0
        

</TABLE>